STERIS plc STE | NYSE

$222.97 $0.73 | 0.33%

Next Earnings: May 14, 2025

Company Overview:

Market Cap: $21.91B
PE Ratio: 35.79
52-Week Range: $200.98 - $248.24
Dividend Yield (FWD): 1.03% ($2.28)

10 Year Performance Metrics:

Total Return (with DRIP): 265.84% (13.85% / yr)
Total Return (no DRIP): 249.71% (13.34% / yr)
Share Price: 227.02%
Dividend Increase: 147.83
STE 10-yr Total Return ($10K invested)
1Y 2Y 5Y 10Y All

STE Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
STE Dividend CAGR:1Y: 9.62%2Y: 10.13%5Y: 9.03%10Y: 9.50%
Share Price
STE Price CAGR:1Y: 8.39%2Y: 7.56%5Y: 9.46%10Y: 12.77%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

STE Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend Payout Ratio - STE
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - STE
14-Day FREE Trial Get Full Access Now!

STE Earnings, Revenue, Cash & Debt, Shares Outstaning:

STE - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
STE - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
STE - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
STE - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
STE - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
STE - Cash & Debt
14-Day FREE Trial Get Full Access Now!
STE - Revenue
14-Day FREE Trial Get Full Access Now!
STE Revenue CAGR:1Y: -1.80%2Y: 6.17%5Y: 12.10%10Y: 11.22%
STE - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
STE EPS CAGR:1Y: 23.24%2Y: 18.80%5Y: 7.31%10Y: 10.76%
STE - Net Income
14-Day FREE Trial Get Full Access Now!
STE Net Income CAGR:1Y: 23.30%2Y: 18.38%5Y: 10.59%10Y: 16.36%
STE - EBITDA
14-Day FREE Trial Get Full Access Now!
STE EBITDA CAGR:1Y: -32.34%2Y: 13.36%5Y: 4.93%10Y: 15.29%
STE - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
STE Free Cash Flow CAGR:1Y: 41.38%2Y: 46.34%5Y: 26.29%10Y: 19.78%
STE - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
STE Free Cash Flow / Share CAGR:1Y: 41.83%2Y: 47.24%5Y: 22.56%10Y: 13.89%
STE - Gross Profit
14-Day FREE Trial Get Full Access Now!
STE Gross Profit CAGR:1Y: 1.28%2Y: 8.18%5Y: 12.99%10Y: 11.96%
STE - Expenses
14-Day FREE Trial Get Full Access Now!
STE Expenses CAGR:1Y: -24.98%2Y: -1.42%5Y: 9.97%10Y: 16.00%
STE - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
STE Shares Outstanding CAGR:1Y: -0.41%2Y: -0.61%5Y: 2.93%10Y: 5.10%
STE - Share Buybacks
14-Day FREE Trial Get Full Access Now!
STE Share Buybacks CAGR:1Y: 4,409.79%2Y: 9.33%5Y: 110.05%10Y: 21.21%
STE - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
STE Stock-Based Comp CAGR:1Y: 0.27%2Y: 28.09%5Y: 22.38%10Y: 14.96%
STE - Dividends
14-Day FREE Trial Get Full Access Now!
STE Dividend CAGR:1Y: 9.62%2Y: 10.13%5Y: 9.03%10Y: 9.50%
STE - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
STE Revenue CAGR:1Y: -1.80%2Y: 6.17%5Y: 12.10%10Y: 11.22%
STE - Revenue by Region
14-Day FREE Trial Get Full Access Now!
STE Revenue CAGR:1Y: -1.80%2Y: 6.17%5Y: 12.10%10Y: 11.22%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

STE - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
STE Actual Revenue CAGR:1Y: -1.80%2Y: 6.17%5Y: 12.10%10Y: 11.22%
STE - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
STE Actual EPS CAGR:1Y: 23.24%2Y: 18.80%5Y: 7.31%10Y: 10.76%
STE - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
STE Actual Net Income CAGR:1Y: 23.30%2Y: 18.38%5Y: 10.59%10Y: 16.36%
STE - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
STE Actual EBITDA CAGR:1Y: -32.34%2Y: 13.36%5Y: 4.93%10Y: 15.29%

Ratios, Profit Margins & Return on Capital:

STE - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
STE Net Profit Margin CAGR:1Y: 25.60%2Y: 11.52%5Y: -1.35%10Y: 4.62%
STE - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
STE Gross Profit Margin CAGR:1Y: 3.13%2Y: 1.89%5Y: 0.80%10Y: 0.67%
STE - Price to Earnings
14-Day FREE Trial Get Full Access Now!
STE - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
STE - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
STE - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

STE Dividends Info:

Annual Dividend: $2.28
Forward Yield: 1.02%
Ex-Dividend Date: 2025-02-20
Lifetime Dividens / Share: $22.41

STE Dividend History: Dates, Payments & Yield list

Below is a schedule of all STE dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date
02/20/202503/21/2025$0.5701.01%1.03%$220.79
11/19/202412/19/2024$0.5701.03%1.08%$212.00
09/05/202409/20/2024$0.5700.89%0.95%$239.05
06/12/202406/26/2024$0.5200.92%0.92%$225.84
02/22/202403/22/2024$0.5200.86%0.88%$236.03
11/20/202312/21/2023$0.5200.99%1.04%$199.80
09/05/202309/22/2023$0.5200.86%0.93%$223.64
06/13/202306/28/2023$0.4700.91%0.91%$207.59
02/23/202303/23/2023$0.4700.98%1%$187.85
11/21/202212/16/2022$0.4701.02%1.06%$177.21
09/06/202209/23/2022$0.4700.89%0.95%$197.39
06/13/202206/28/2022$0.4300.81%0.81%$211.23
02/24/202203/24/2022$0.4300.74%0.75%$229.21
11/22/202112/17/2021$0.4300.72%0.74%$230.96
09/02/202109/24/2021$0.4300.75%0.79%$218.07
05/27/202106/25/2021$0.4000.84%0.84%$190.89
02/23/202103/25/2021$0.4000.91%0.92%$173.27
11/23/202012/18/2020$0.4000.81%0.85%$189.09
08/26/202009/24/2020$0.4000.98%1.04%$154.27
06/11/202006/26/2020$0.3700.99%0.99%$149.33
02/24/202003/26/2020$0.3700.87%0.88%$167.46
11/25/201912/20/2019$0.3700.94%0.98%$151.50
09/09/201909/26/2019$0.3700.96%1.02%$145.28
06/11/201906/28/2019$0.3400.97%0.97%$140.45
02/26/201903/21/2019$0.3401.1%1.13%$120.56
11/27/201812/21/2018$0.3401.13%1.18%$114.81
08/28/201809/27/2018$0.3401.11%1.18%$114.93
06/07/201806/28/2018$0.3101.18%1.18%$104.70
02/27/201803/28/2018$0.3101.31%1.35%$92.03
11/21/201712/20/2017$0.3101.33%1.4%$88.58
08/25/201709/28/2017$0.3101.35%1.46%$84.91
06/05/201706/29/2017$0.2801.42%1.42%$79.06
02/24/201703/28/2017$0.2801.55%1.59%$70.25
11/21/201612/21/2016$0.2801.59%1.68%$66.69
08/26/201609/27/2016$0.2801.47%1.6%$70.14
06/06/201606/29/2016$0.2501.42%1.42%$70.27
02/26/201603/29/2016$0.2501.52%1.55%$64.54
10/28/201512/18/2015$0.2501.35%1.41%$71.04
08/21/201509/22/2015$0.2501.46%1.55%$64.32
06/01/201506/25/2015$0.2301.36%1.36%$67.46
02/23/201503/25/2015$0.2301.37%1.4%$65.54
11/24/201412/23/2014$0.2301.39%1.45%$63.30
08/22/201409/23/2014$0.2301.55%1.66%$55.35
06/03/201406/26/2014$0.2101.61%1.61%$52.16
02/24/201403/26/2014$0.2101.81%1.86%$45.19
11/18/201312/18/2013$0.2101.79%1.88%$44.73
08/26/201309/25/2013$0.2101.83%1.97%$42.59
05/31/201306/25/2013$0.1901.68%1.68%$45.34
02/25/201303/27/2013$0.1901.92%1.97%$38.60
11/19/201212/19/2012$0.1902.18%2.3%$33.10
08/21/201209/20/2012$0.1902.04%2.22%$34.30
06/01/201206/26/2012$0.1702.34%2.34%$29.01
02/24/201203/27/2012$0.1702.05%2.12%$32.13
11/21/201112/21/2011$0.1702.29%2.43%$27.97
08/19/201109/20/2011$0.1702.17%2.38%$28.61
06/03/201106/28/2011$0.1501.74%1.74%$34.45
02/25/201103/29/2011$0.1501.64%1.76%$34.14
11/22/201012/22/2010$0.1501.51%1.74%$34.48
08/20/201009/21/2010$0.1508.43%2.04%$29.42
05/25/201006/15/2010$0.1107.79%1.4%$31.34
02/19/201003/23/2010$0.1107.72%1.39%$31.61
11/20/200912/22/2009$2.1107.57%26.52%$31.83
08/18/200909/17/2009$0.1101.34%1.55%$28.31
05/19/200906/18/2009$0.1101.46%1.83%$24.05
02/09/200903/11/2009$0.0801.07%1.15%$27.92
11/06/200812/09/2008$0.0800.84%0.96%$33.30
08/12/200809/11/2008$0.0800.7%0.87%$36.96
05/12/200806/11/2008$0.0600.76%0.76%$31.50
02/08/200803/11/2008$0.0600.99%1.03%$23.20
11/09/200712/12/2007$0.0600.81%0.89%$27.05
08/13/200709/12/2007$0.0600.74%0.85%$28.36
05/14/200706/13/2007$0.0500.69%0.73%$27.47
02/09/200703/13/2007$0.0500.69%0.76%$26.26
11/13/200612/13/2006$0.0500.67%0.79%$25.20
08/14/200609/13/2006$0.0400.71%0.71%$22.52
05/15/200606/14/2006$0.0400.69%0.69%$23.20
02/06/200603/08/2006$0.0400.63%0.63%$25.55
11/14/200512/07/2005$0.0400.49%0.65%$24.74
08/10/200509/09/2005$0.0400.31%0.62%$25.91
05/26/200506/28/2005$0.0400.17%0.66%$24.13

Projected Future Returns & Dividends for STE

Based on past 10-year performance, here are STE growth metrics:

Share price CAGR of +12.77%
Dividend CAGR of +9.51%

Using STE CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

STE (DRIP)STE - No DRIP
Current Price$222.24$222.24
Start Shares45.0045.00
Start Value$10,000$10,000
  
After 10 years:
Final Share Count49.2445.00
Dividends Payment$1.41$1.41
Annual Dividends$278$254
Yield on cost2.78%2.54%
Share Price$655.46$655.46
Total Dividends$1,684$1,597
Final Value$32,275$31,090

Estimated Future Value + Dividends - STE

NOTE: Above numbers are our estimate based on STE's Dividend and Price CAGR over past 10 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Company Info

STERIS plc (STE) had its IPO on 1992-06-01, and is trader on NYSE stock exchange.

STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier and sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and powered dental instruments, infection control products, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

STE website: https://www.steris.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 25% OFF
$135/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial